Arun Renganathan
- Drug Discovery top 0.5%
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 4
- Materials Chemistry top 5%
- Nanoparticles: synthesis and applications 6
- Biomaterials top 10%
-
- Metal complexes synthesis and properties 4
- Cancer Immunotherapy and Biomarkers 2
-
- RNA modifications and cancer 3
- RNA Research and Splicing 3
- Ubiquitin and proteasome pathways 2
-
- Graphene and Nanomaterials Applications 3
- Co-authors
- Emanuela Felley‐BoscoKumpati PremkumarGnanasekar SathishkumarMurugaraj JeyarajChirom AartiNooruddin ThajuddinMarkandan ManickavasagamDavoodbasha MubarakAli
- Journals
- Nature Communications (1 paper)Scientific Reports (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- IndiaUnited StatesSwitzerland
In The Last Decade
Arun Renganathan
24 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Drug Discovery 10
- Cancer Research 302
- Complementary and alternative medicine 152
- Materials Chemistry 809
- Biomaterials 171
Countries citing papers authored by Arun Renganathan
This map shows the geographic impact of Arun Renganathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arun Renganathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arun Renganathan more than expected).
Fields of papers citing papers by Arun Renganathan
This network shows the impact of papers produced by Arun Renganathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arun Renganathan. The network helps show where Arun Renganathan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arun Renganathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 36 | |
| 7 | 2019 | 14 | |
| 8 | 2017 | 20 | |
| 9 | 2017 | 203 | |
| 10 | 2015 | 16 | |
| 11 | SYNTHESIS AND CHARACTERIZATION OF SILVER NANOPARTICLES USING TABERNAEMONTANA DIVARICATA AND ITS CYTOTOXIC ACTIVITY AGAINST MCF-7 CELL LINE | 2014 | 12 |
| 12 | 2014 | 74 | |
| 13 | 2014 | 11 | |
| 14 | 2014 | 62 | |
| 15 | 2013 | 18 | |
| 16 | 2013 | 365 | |
| 17 | 2013 | 39 | |
| 18 | 2012 | 30 | |
| 19 | 2012 | 243 | |
| 20 | 2010 | 54 |
About Arun Renganathan
Arun Renganathan is a scholar working on Cancer Research, Oncology and Developmental Neuroscience, having authored 25 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticles: synthesis and applications (6 papers), Metal complexes synthesis and properties (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers), Graphene and Nanomaterials Applications (3 papers), RNA Research and Splicing (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Drug Discovery (10 citations), Cancer Research (302 citations) and Complementary and alternative medicine (152 citations). Arun Renganathan has collaborated with scholars based in India, United States and Switzerland. Frequent co-authors include Emanuela Felley‐Bosco, Kumpati Premkumar, Gnanasekar Sathishkumar, Murugaraj Jeyaraj, Chirom Aarti, Nooruddin Thajuddin, Markandan Manickavasagam, Davoodbasha MubarakAli, Ganeshan Sivanandhan and A. Ganapathi. Their work appears in journals such as Nature Communications, Scientific Reports and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.